Literature DB >> 27939321

Transfer of a three step mAb chromatography process from batch to continuous: Optimizing productivity to minimize consumable requirements.

Xhorxhi Gjoka1, Rene Gantier1, Mark Schofield2.   

Abstract

The goal of this study was to adapt a batch mAb purification chromatography platform for continuous operation. The experiments and rationale used to convert from batch to continuous operation are described. Experimental data was used to design chromatography methods for continuous operation that would exceed the threshold for critical quality attributes and minimize the consumables required as compared to batch mode of operation. Four unit operations comprising of Protein A capture, viral inactivation, flow-through anion exchange (AEX), and mixed-mode cation exchange chromatography (MMCEX) were integrated across two Cadence BioSMB PD multi-column chromatography systems in order to process a 25L volume of harvested cell culture fluid (HCCF) in less than 12h. Transfer from batch to continuous resulted in an increase in productivity of the Protein A step from 13 to 50g/L/h and of the MMCEX step from 10 to 60g/L/h with no impact on the purification process performance in term of contaminant removal (4.5 log reduction of host cell proteins, 50% reduction in soluble product aggregates) and overall chromatography process yield of recovery (75%). The increase in productivity, combined with continuous operation, reduced the resin volume required for Protein A and MMCEX chromatography by more than 95% compared to batch. The volume of AEX membrane required for flow through operation was reduced by 74%. Moreover, the continuous process required 44% less buffer than an equivalent batch process. This significant reduction in consumables enables cost-effective, disposable, single-use manufacturing.
Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cadence BioSMB PD; Continuous chromatography; Monoclonal antibody (mAb); Process intensification; Productivity

Mesh:

Substances:

Year:  2016        PMID: 27939321     DOI: 10.1016/j.jbiotec.2016.12.005

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  7 in total

Review 1.  Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development.

Authors:  Nagesh K Tripathi; Ambuj Shrivastava
Journal:  Front Bioeng Biotechnol       Date:  2019-12-20

2.  Economic Analysis of Batch and Continuous Biopharmaceutical Antibody Production: A Review.

Authors:  Ou Yang; Maen Qadan; Marianthi Ierapetritou
Journal:  J Pharm Innov       Date:  2019-01-25       Impact factor: 2.750

3.  Integrated flow-through purification for therapeutic monoclonal antibodies processing.

Authors:  Takamitsu Ichihara; Takao Ito; Yasuhiko Kurisu; Kevin Galipeau; Christopher Gillespie
Journal:  MAbs       Date:  2018-01-16       Impact factor: 5.857

4.  Truly continuous low pH viral inactivation for biopharmaceutical process integration.

Authors:  Duarte L Martins; Jure Sencar; Nikolaus Hammerschmidt; Andreas Flicker; Johanna Kindermann; Thomas R Kreil; Alois Jungbauer
Journal:  Biotechnol Bioeng       Date:  2020-02-24       Impact factor: 4.530

5.  Scalable, Robust and Highly Productive Novel Convecdiff Membrane Platform for mAb Capture.

Authors:  Mario Grünberg; Kim B Kuchemüller; Katrin Töppner; Ricarda A Busse
Journal:  Membranes (Basel)       Date:  2022-06-30

6.  Membrane Adsorber for the Fast Purification of a Monoclonal Antibody Using Protein A Chromatography.

Authors:  Chantal Brämer; Lisa Tünnermann; Alina Gonzalez Salcedo; Oscar-Werner Reif; Dörte Solle; Thomas Scheper; Sascha Beutel
Journal:  Membranes (Basel)       Date:  2019-11-27

Review 7.  White paper on high-throughput process development for integrated continuous biomanufacturing.

Authors:  Mariana N São Pedro; Tiago C Silva; Rohan Patil; Marcel Ottens
Journal:  Biotechnol Bioeng       Date:  2021-04-02       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.